These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 611808)

  • 1. [Studies on fibrinolysis in patient with metastasizing malignancies and in patients with non-metastasizing brain tumors].
    Scharrer I; Hübner H
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1144-8. PubMed ID: 611808
    [No Abstract]   [Full Text] [Related]  

  • 2. [Factors of the fibrinolysis of the vascular wall in patients with different severity of atherosclerosis and of different age].
    Kovalenko AN
    Biull Eksp Biol Med; 1982 Jan; 93(1):26-8. PubMed ID: 7199953
    [No Abstract]   [Full Text] [Related]  

  • 3. The role of hemostasis and fibrinolysis in the metastatic spread of cancer.
    Markus G
    Semin Thromb Hemost; 1984 Jan; 10(1):61-70. PubMed ID: 6538342
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of angiotensin II on indices of the fibrinolysis system in experiments in vitro].
    Golubenkova NI
    Lab Delo; 1981; (12):720-2. PubMed ID: 6172641
    [No Abstract]   [Full Text] [Related]  

  • 5. Peripheral and gastric fibrinolysis in peptic ulcer patients.
    Prokopowicz J; Gabryelewicz A; Wolosowicz N; Puchalski Z; Tolloczko A
    Haematologia (Budap); 1973; 7(3):381-4. PubMed ID: 4790076
    [No Abstract]   [Full Text] [Related]  

  • 6. Separation and characterization of two fibrinolytic inhibitors from human placenta.
    Uszynski M; Abildgaard U
    Thromb Diath Haemorrh; 1971 Jun; 25(3):580-9. PubMed ID: 4998018
    [No Abstract]   [Full Text] [Related]  

  • 7. [Role of plasminogen activators in cancer dissemination. Clinical perspectives].
    Alonso DF; Bal de Kier Joffé E
    Medicina (B Aires); 1992; 52(3):252-6. PubMed ID: 1342692
    [No Abstract]   [Full Text] [Related]  

  • 8. The fibrinolytic system in South African white and Bantu men.
    Lackner H; Johnson AJ
    Thromb Diath Haemorrh; 1967 Dec; 18(3-4):456-61. PubMed ID: 5590238
    [No Abstract]   [Full Text] [Related]  

  • 9. Influence of ethanol and acetaldehyde on fibrinolytic system (examinations in vitro).
    Skrzydlewska E; Worowski K
    Rocz Akad Med Im Juliana Marchlewskiego Bialymst; 1984-1985; 29-30():163-73. PubMed ID: 6242841
    [No Abstract]   [Full Text] [Related]  

  • 10. [Tissue plasminogen activator activity in early prostatic cancer and in bone metastases of prostatic cancer].
    Pflüger H; Kirchheimer J; Ritschl P; Köller A; Hienert G; Binder BR
    Wien Klin Wochenschr; 1984 Sep; 96(17):658-61. PubMed ID: 6083673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Tumor metastasis and the fibrinolytic system].
    Yamamura M; Yamamoto M
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-1):1246-54. PubMed ID: 2730023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrinolysis system in patients with bronchial asthma.
    Banach-Wawrzeńczyk E; Dziedziczko A; Rość D
    Med Sci Monit; 2000; 6(1):103-7. PubMed ID: 11208294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Role of plasminogen activators in the development of tumors and the process of their metastasis].
    Liaginskiĭ AV; Egorov BB
    Vopr Onkol; 1989; 35(12):1418-25. PubMed ID: 2692282
    [No Abstract]   [Full Text] [Related]  

  • 14. [On the difference between serum and euglobulin in determination of fibrinolytic activities by streptokinase-activated method with special reference to the relationship with antiplasmin agents].
    Miyatani K; Fukui I
    Rinsho Byori; 1971 Mar; 19(3):223-6. PubMed ID: 4252723
    [No Abstract]   [Full Text] [Related]  

  • 15. Chronic intravascular coagulation. Clinical spectrum and diagnostic criteria, with special emphasis on metabolism, distribution and localization of I 131 -fibrinogen.
    Straub PW
    Acta Med Scand Suppl; 1971; 526():1-95. PubMed ID: 5292077
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of the leukocytes from chronic lympholeukemia patients on fibrinolysis].
    Krasik IaD
    Probl Gematol Pereliv Krovi; 1978 Apr; 23(4):24-30. PubMed ID: 652750
    [No Abstract]   [Full Text] [Related]  

  • 17. Plasminogen activators in human malignant melanoma.
    Markus G; Kohga S; Camiolo SM; Madeja JM; Ambrus JL; Karakousis C
    J Natl Cancer Inst; 1984 Jun; 72(6):1213-22. PubMed ID: 6374238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Activators and inhibitors of blood coagulation and fibrinolysis in the human placenta and myometrium].
    Uszyński M
    Rocz Akad Med Im Juliana Marchlewskiego Bialymst; 1971; 16():159-90. PubMed ID: 5004447
    [No Abstract]   [Full Text] [Related]  

  • 19. [The stimulation of fibrinolysis during cholinergic vasodilating reactions].
    Bashkov GV; Sergeev IIu; Medvedeva NA; Makarov VA
    Fiziol Zh (1978); 1990; 36(4):3-8. PubMed ID: 2146171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibrinolysis and antifibrinolytic drugs in the growth and spread of tumours.
    Peterson H
    Cancer Treat Rev; 1977 Sep; 4(3):213-7. PubMed ID: 589607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.